In a significant development for the DeepTech sector, Tunisian startup MIGSens and Italian startup Sense4Med have signed an agreement for technology transfer and distribution. The deal, inked on October 28-30, 2026, during the Euro-Mediterranean Conference on Materials, Devices and Systems in Port El Kantaoui, Tunisia, marks a first for the country. MIGSens is represented by Firas Karaoui, while Sense4Med is represented by Arduini Fabiana.
The agreement focuses on the development and distribution of rapid testing kits for biomarkers such as chloride ions, lactic acid, sodium, and cortisol. These kits, made from flexible materials and paper, enable quick, specific, and non-invasive measurements in human sweat. The biomarkers targeted by the kits are associated with conditions like cystic fibrosis, hydration levels, tissue ischemia, and chronic stress.
The testing kits are designed to be eco-friendly, cost-effective, portable, and less invasive than traditional methods. This innovation has the potential to revolutionize healthcare and diagnostics in Tunisia and beyond. The partnership between MIGSens and Sense4Med is expected to yield further developments in environmental and agro-food applications.
The Euro-Mediterranean Conference, which hosted the signing of the agreement, is a significant event in the region. Organized by the National Institute of Applied Sciences and Technology of the University of Carthage, in partnership with the University of Grenoble Alpes and the National Institute of Applied Sciences of Lyon, the conference brings together experts in materials, devices, and systems.
The deal between MIGSens and Sense4Med underscores the growing importance of DeepTech in Tunisia. As the country continues to develop its technological capabilities, collaborations like this one are likely to play a crucial role in driving innovation and growth. The involvement of universities and research institutions in such initiatives highlights the potential for academic-industrial partnerships to drive progress.
The rapid testing kits developed through this partnership have the potential to make a significant impact on public health in Tunisia and other regions. By enabling early detection and monitoring of various conditions, these kits can help improve healthcare outcomes and quality of life. The agreement also paves the way for further research and development in the field of biomarkers and diagnostic tools.
As Tunisia's DeepTech sector continues to evolve, initiatives like the partnership between MIGSens and Sense4Med are likely to serve as models for future collaborations. With a focus on innovation, sustainability, and social impact, such partnerships can help drive economic growth and improve lives in the region.
Key points
- The agreement between MIGSens and Sense4Med marks a significant milestone in the development of Tunisia's DeepTech sector.
- The rapid testing kits developed through this partnership have the potential to revolutionize healthcare and diagnostics in Tunisia and beyond.
- The partnership between MIGSens and Sense4Med is expected to yield further developments in environmental and agro-food applications.
